封面
市場調查報告書
商品編碼
1540797

2024-2032 年按分析類型、組件類型、技術、應用、最終用戶(臨床診斷實驗室、研究組織等)和地區分類的蛋白質組學市場報告

Proteomics Market Report by Analysis Type, Component Type, Technology, Application, End-User (Clinical Diagnostic Laboratories, Research Organizations, and Others), and Region 2024-2032

出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

2023年全球蛋白質體IMARC Group規模達363億美元。

蛋白質體學是指大規模研究蛋白質體、其結構和生理功能。 1994 年,馬克·威爾金斯 (Mark Wilkins) 首次為從基因組翻譯而來的蛋白質創造了術語“蛋白質組”,以表示在活生物體中合成的整套蛋白質。它涵蓋了現有蛋白質在暴露於不同條件下時所發生的修飾和變化。蛋白質體學應用各種技術來定量和鑑定蛋白質,以及檢測診斷標記、了解細胞中的病原體以及解釋不同疾病中的蛋白質途徑。它還評估蛋白質產生的速率和蛋白質的相互作用模式,因此它在藥物發現和個人化藥物的開發中具有廣泛的適用性。

對個人化藥物的日益青睞,以及藥物發現和生物技術研究和開發的不斷增加,是推動市場成長的關鍵因素。蛋白質組系統減少了藥物化學合成和生物測試所需的時間、成本和資源,並簡化了藥物發現過程。此外,與生物標記識別和基於質譜的蛋白質組學相關的機會進一步有利於市場成長。此外,蛋白質綜合分析技術的技術滲透率不斷提高,也推動了市場的發展。這些技術包括電噴霧電離-液相層析-質譜(ESI-LC-MS)、表面等離子體共振、微陣列、蛋白質分級分離系統和X光晶體學。這些進步使得能夠對蛋白質進行徹底的定量和定性分析以及癌症療法和治療方法的鑑定。其他因素,例如政府對廣泛研發(R&D)的有利政策,也促進了市場的成長。

本報告回答的關鍵問題

  • 全球蛋白質體學市場有多大? 2024-2032年全球蛋白質體學市場的預期成長率是多少?
  • 推動全球蛋白質體學市場的關鍵因素是什麼?
  • COVID-19 對全球蛋白質體學市場有何影響?
  • 基於該技術的全球蛋白質體學市場的詳細情形如何?
  • 基於最終用戶的全球蛋白質體學市場的分類是怎樣的?
  • 全球蛋白質體學市場的關鍵區域有哪些?
  • 誰是全球蛋白質體學市場的主要參與者/公司?

目錄

第1章:前言

第 2 章:範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章:執行摘要

第 4 章:簡介

  • 概述
  • 主要行業趨勢

第 5 章:全球蛋白質體學市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章:市場區隔:按分析類型

  • 結構蛋白質體學
    • 市場趨勢
    • 市場預測
  • 功能蛋白質體學
    • 市場趨勢
    • 市場預測
  • 蛋白質表現蛋白質體學
    • 市場趨勢
    • 市場預測

第 7 章:市場區隔:按組件類型

  • 核心蛋白質體學服務
    • 市場趨勢
    • 市場預測
  • 生物資訊軟體及相關服務
    • 市場趨勢
    • 市場預測

第 8 章:市場區隔:依技術

  • 光譜學
    • 市場趨勢
    • 市場預測
  • 色譜法
    • 市場趨勢
    • 市場預測
  • 電泳
    • 市場趨勢
    • 市場預測
  • 蛋白質微陣列
    • 市場趨勢
    • 市場預測
  • X光晶體學
    • 市場趨勢
    • 市場預測
  • 表面等離子共振
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 9 章:市場區隔:按應用

  • 蛋白質表現譜
    • 市場趨勢
    • 市場預測
  • 蛋白質體挖掘
    • 市場趨勢
    • 市場預測
  • 翻譯後修飾
    • 市場趨勢
    • 市場預測

第 10 章:市場區隔:依最終用戶

  • 臨床診斷實驗室
    • 市場趨勢
    • 市場預測
  • 研究組織(藥物發現)
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 11 章:市場區隔:按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分:按國家/地區
    • 市場預測

第 12 章:SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 13 章:價值鏈分析

第 14 章:波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第15章:競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Agilent Technologies Inc.
    • Bio-RAD Laboratories Inc.
    • Bruker Corporation
    • Creative Proteomics
    • Danaher Corporation
    • GE Healthcare Inc.
    • Horiba Ltd.
    • Luminex Corporation
    • Merck Group
    • Perkinelmer Inc.
    • Promega Corporation
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
Product Code: SR112024A2156

The global proteomics market size reached US$ 36.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 126.2 Billion by 2032, exhibiting a growth rate (CAGR) of 14.4% during 2024-2032.

Proteomics refers to the study of proteomes, their structure and physiological functions on a large-scale. In 1994, Mark Wilkins first coined the term proteome for the proteins that are translated from genome, to denote the whole set of proteins synthesized within a living organism. It encompasses the modifications and alterations that take place in the existing protein when it is exposed to varying conditions. Proteomics applies various technologies for the quantification and identification of proteins, along with the detection of diagnostic markers, understanding of pathogens in cells and interpretation of protein pathways in different diseases. It also evaluates the rate of protein production and the interaction patterns of proteins due to which it finds extensive applicability in drug discovery and the development of personalized medications.

The growing preference for personalized drugs, along with increasing research and development in drug discovery and biotechnology, is the key factor driving the growth of the market. Proteomic systems reduce the time, cost and resources needed for the chemical synthesis and biological testing of drugs and simplify the process of drug discovery. Furthermore, opportunities related to biomarker identification and mass spectrometry-based proteomics are favoring the market growth further. Additionally, the market is driven by increasing technological penetration in the comprehensive analysis of protein techniques. These techniques include Electrospray Ionization-Liquid Chromatography-Mass Spectrometry (ESI-LC-MS), surface plasma resonance, microarray, protein fractionation systems and X-ray crystallography. These advancements enable a thorough quantitative and qualitative analysis of proteins and identification of cancer therapies and treatments. Other factors, such as favorable government policies for extensive research and development (R&D) are also augmenting the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global proteomics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on analysis type, component type, technology, application and end-user.

Breakup by Analysis Type:

Structural Proteomics

Functional Proteomics

Protein Expression Proteomics

Breakup by Component Type:

Core Proteomics Services

Bioinformatics Software and Related Services

Breakup by Technology:

Spectroscopy

Chromatography

Electrophoresis

Protein Microarrays

X-Ray Crystallography

Surface Plasmon Resonance

Others

Breakup by Application:

Protein Expression Profiling

Proteome Mining

Post-translational Modifications

Breakup by End-User:

Clinical Diagnostic Laboratories

Research Organizations (Drug Discovery)

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Bio-RAD Laboratories Inc., Bruker Corporation, Creative Proteomics, Danaher Corporation, GE Healthcare Inc., Horiba Ltd., Luminex Corporation, Merck Group, Perkinelmer Inc., Promega Corporation, Thermo Fisher Scientific Inc., Waters Corporation, etc.

Key Questions Answered in This Report

  • 1. How big is the global proteomics market?
  • 2. What is the expected growth rate of the global proteomics market during 2024-2032?
  • 3. What are the key factors driving the global proteomics market?
  • 4. What has been the impact of COVID-19 on the global proteomics market?
  • 5. What is the breakup of the global proteomics market based on the technology?
  • 6. What is the breakup of the global proteomics market based on the end-user?
  • 7. What are the key regions in the global proteomics market?
  • 8. Who are the key players/companies in the global proteomics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Proteomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Analysis Type

  • 6.1 Structural Proteomics
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Functional Proteomics
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Protein Expression Proteomics
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Component Type

  • 7.1 Core Proteomics Services
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Bioinformatics Software and Related Services
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Spectroscopy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Chromatography
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Electrophoresis
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Protein Microarrays
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 X-Ray Crystallography
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Surface Plasmon Resonance
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Protein Expression Profiling
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Proteome Mining
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Post-translational Modifications
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Clinical Diagnostic Laboratories
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Research Organizations (Drug Discovery)
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Agilent Technologies Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bio-RAD Laboratories Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bruker Corporation
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Creative Proteomics
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Danaher Corporation
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 GE Healthcare Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Horiba Ltd.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Luminex Corporation
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Merck Group
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Perkinelmer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Promega Corporation
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Waters Corporation
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Proteomics Market: Major Drivers and Challenges
  • Figure 2: Global: Proteomics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Proteomics Market: Breakup by Analysis Type (in %), 2023
  • Figure 4: Global: Proteomics Market: Breakup by Component Type (in %), 2023
  • Figure 5: Global: Proteomics Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Proteomics Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Proteomics Market: Breakup by End-User (in %), 2023
  • Figure 8: Global: Proteomics Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Proteomics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 10: Global: Proteomics (Structural Proteomics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Proteomics (Structural Proteomics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Proteomics (Functional Proteomics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Proteomics (Functional Proteomics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Proteomics (Protein Expression Proteomics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Proteomics (Protein Expression Proteomics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Proteomics (Core Proteomics Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Proteomics (Core Proteomics Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Proteomics (Bioinformatics Software and Related Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Proteomics (Bioinformatics Software and Related Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Proteomics (Spectroscopy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Proteomics (Spectroscopy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Proteomics (Chromatography) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Proteomics (Chromatography) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Proteomics (Electrophoresis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Proteomics (Electrophoresis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Proteomics (Protein Microarrays) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Proteomics (Protein Microarrays) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Proteomics (X-Ray Crystallography) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Proteomics (X-Ray Crystallography) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Proteomics (Surface Plasmon Resonance) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Proteomics (Surface Plasmon Resonance) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Proteomics (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Proteomics (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Proteomics (Protein Expression Profiling) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Proteomics (Protein Expression Profiling) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Proteomics (Proteome Mining) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Proteomics (Proteome Mining) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Proteomics (Post-translational Modifications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Proteomics (Post-translational Modifications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Proteomics (Clinical Diagnostic Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Proteomics (Clinical Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Proteomics (Research Organizations-Drug Discovery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Proteomics (Research Organizations-Drug Discovery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Global: Proteomics (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Global: Proteomics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: North America: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: North America: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: United States: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: United States: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Canada: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Canada: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Asia Pacific: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Asia Pacific: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: China: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: China: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Japan: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Japan: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: India: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: India: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: South Korea: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: South Korea: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Australia: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Australia: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Indonesia: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Indonesia: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Europe: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Europe: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Germany: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Germany: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: France: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: France: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: United Kingdom: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: United Kingdom: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Italy: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Italy: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Spain: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Spain: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Russia: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Russia: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Others: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Others: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Latin America: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Latin America: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Brazil: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Brazil: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Mexico: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 89: Mexico: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: Others: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 91: Others: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 92: Middle East and Africa: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 93: Middle East and Africa: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 94: Global: Proteomics Industry: SWOT Analysis
  • Figure 95: Global: Proteomics Industry: Value Chain Analysis
  • Figure 96: Global: Proteomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Proteomics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Proteomics Market Forecast: Breakup by Analysis Type (in Million US$), 2024-2032
  • Table 3: Global: Proteomics Market Forecast: Breakup by Component Type (in Million US$), 2024-2032
  • Table 4: Global: Proteomics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 5: Global: Proteomics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Proteomics Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 7: Global: Proteomics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Proteomics Market Structure
  • Table 9: Global: Proteomics Market: Key Players